In the o que e que pareco aldactone absence of metabolic activation, aldactone meksiko neither spironolactone nor potassium canrenoate has been shown to aldactone espana be mutagenic in mammalian tests in vitro.
March 27, 2009
In the absence of metabolic activation, neither spironolactone nor potassium canrenoate has been shown to be mutagenic in mammalian tests in vitro. Edematous conditions for patients with: Congestive heart failure For the kob aldactone management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with Aldactone.